We performed an in vitro examination of the inotropic effect of oxytoc
in, chlorobutanol, and their combination to assess the effect of these
drugs on the contractile force of human atrial trabeculae. Right atri
al tissue samples were obtained during cardiac surgery with cardiopulm
onary bypass. Trabeculae of the atrial appendage were dissected and mo
unted on muscle stands in a modified Krebs-Henseleit buffer bath. This
isometric atrial trabecula preparation was subjected to a cumulative
pharmacological protocol of either pure oxytocin, pure chlorobutanol,
or a combination of the two drugs until no further change occurred in
either developed force or resting force of the atrial trabeculae. A ''
no drug'' buffer solution was used to assess the effect of time on the
natural decay of the atrial preparation. The relative developed force
of oxytocin plus chlorobutanol solution and pure chlorobutanol were s
imilar in magnitude and lower than that in control experiments (P < 0.
001) Pure oxytocin did not change the contractile force of atrial tiss
ue. We conclude that pure oxytocin does not have a cardiodepressive ef
fect in this human atrial preparation. Chlorobutanol has a negative in
otropic effect, which is of a magnitude similar to a combined solution
of chlorobutanol and oxytocin. Therefore, chlorobutanol added as a pr
eservative to the commercial synthetic;oxytocin solution may contribut
e to hypotension observed in patients after an intravenous bolus injec
tion. Implications: We obtained specimens of heart tissue from patient
s undergoing cardiac surgery and conducted a laboratory study of the e
ffects of oxytocin and its preservative (chlorobutanol) on these tissu
e samples. Chlorobutanol decreased the ability of the heart to contrac
t, while as pure oxytocin had no effect. This explains why maternal bl
ood pressure may decrease and provides impetus to produce oxytocin wit
h another, safer preservative.